A Study to Test the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Condition:   Hidradenitis Suppurativa Interventions:   Drug: Bimekizumab;   Other: Placebo Sponsor:   UCB Biopharma SRL Not yet recruiting

Source: ClinicalTrials.gov - January 27, 2020 Category: Research Source Type: clinical trials